Centro Studi Fegato

  • Chapter on book
  • Full Paper
  • Reviews and Editorials

A hypothesis for using pathway genetic load analysis for understanding complex outcomes in bilirubin encephalopathy

Riordan SM,  Bittel DC, Le Pichon JP, Gazzin S, Tiribelli C, Watchko JF, Wennberg RP, Shapiro SM

Biology of Brain Disorder

Frontiers Cellular Neuroscience

2018

 

Physiology of the liver

Bellarosa C, Tiribelli C

Handbook of gastroenterology and liver diseases

Minerva Medica

2016

Akinetic-rigid and tremor-dominant Parkinson's disease: Two distinct cognitive and behavioral evolutions

Moretti R, Sartori A, Fantini J, Gazzin S

In "Horizons in Neuroscience Research" Volume 18

Nova Science Publishers, Inc

2015

Gait Pathway in Subcortical Vascular Dementia and in Alzheimer’s Disease

Moretti R, Sartori A, Baso B, Gazzin S

In "Alzheimer's Disease - Challenges for the Future" Chapter 11

InTech, DOI: 10.5772/59834, ISBN 978-953-51-2137-4

2015

 

Alcohol and nutrition as risk factors for chronic liver disease

Bellentani S, Tiribelli C, Bedogni G

Nutrition and Health by R.R. Watson et al. (eds.), Springer Science+Business Media New York

2013

Bilirubin metabolism and transport

Bellarosa C, Muchova L,Vitek L, Tiribelli C.

In “Care of the Jaundiced Neonate” by David Stevenson et al(eds), McGraw Hill Companies, Inc.

2012

Disturbances of bilirubin metabolism

Bellarosa C and Tiribelli C

In “Textbook of Clinical Gastroenterology and Hepatology, Second Edition” Wiley Online Library

2012

A beginner's guide to R.

Bedogni G.

Journal of The Royal Statistical Society: SeriesA, July;173:697

2010

Clinical Prediction Models: a practical approach to development, validation and updating

Bedogni G.

Journal of The Royal Statistical Society: Series A;172:944 (Book review)

2009

Statistical models: theory and practice (revised edition)

Bedogni G.

Significance ;4:188 (Book review).

2009

Hyaluronic acid inhibition by 4-methylumbelliferone reduces the expression of cancer stem cells markers during hepatocarcinogenesis

Sukowati CHC, Anfuso B, Fiore E, Ie SI, Raseni A, Radillo O, Avellini C, Mazzolini G, Tiribelli C

Sci Rep 9(1):4026. doi: 10.1038/s41598-019-40436-6

2019

 

Randomized controlled trial on the influence of dietary intervention on epigenetic mechanisms in children with cow's milk allergy: the EPICMA study

Paparo L, Nocerino R, Bruno C, Di Scala C, Cosenza L, Bedogni G, Di Costanzo M, Mennini M, D'Argenio V, Salvatore F, Berni Canani R

Sci Rep. 9(1):2828. doi: 10.1038/s41598-019-38738-w

2019

 

Assessment of fat-free mass from bioelectrical impedance analysis in men and women with Prader-Willi syndrome: cross-sectional study

Bedogni G, Grugni G, Tringali G, Tamini S, Marzullo P, Sartorio A

Int J Food Sci Nutr. Feb 4:1-5. doi: 10.1080/09637486.2018.1554623.

2019

 

Growth pattern, resting energy expenditure, and nutrient intake of children with food allergies

D'Auria E, Fabiano V, Bertoli S, Bedogni G, Bosetti A, Pendezza E, Sartorio MUA, Leone A, Spadafranca A, Borsani B, Stucchi F, Battezzati A, Zuccotti GV

Nutrients 11(2). pii: E212. doi: 10.3390/nu11020212.

2019

 

Association of bright liver with the PNPLA3 I148M gene variant in 1-year-old toddlers

Bedogni G, De Matteis G, Fabrizi M, Alisi A, Crudele A, Pizzolante F, Signore F, Dallapiccola B, Nobili V, Manco M

J Clin Endocrinol Metab. Jan 14. doi: 10.1210/jc.2018-01998                                        

2019

 

Serum AP-endonuclease 1 (sAPE1) as novel biomarker for hepatocellular carcinoma

Pascut D, Sukowati CHC, Antoniali G, Mangiapane G, Burra S, Mascaretti LG, Buonocore MR, Crocè LS, Tiribelli C, Tell G

Oncotarget 10(3):383-394. doi: 10.18632/oncotarget.26555

2019

 

Differences in circulating microRNA signature in Prader-Willi syndrome and non-syndromic obesity

Pascut D, Tamini S, Bresolin S, Giraudi P, Basso G, Minocci A,  Tiribelli C, Grugni G,  Sartorio A

Endocr Connect. 7(12):1262-1274. doi: 10.1530/EC-18-0329

2018

 

Prevalence of and risk factors for fatty liver in the general population of Northern Italy: the Bagnacavallo Study

Foschi FG, Bedogni G, Domenicali M, Giacomoni P, Dall'Aglio AC, Dazzani F, Lanzi A, Conti F, Savini S, Saini G, Bernardi M, Andreone P, Gastaldelli A, Casadei Gardini A, Tiribelli C, Bellentani S, Stefanini GF

BMC Gastroenterol. 18(1):177. doi: 10.1186/s12876-018-0906-

2018

 

Bilirubin-induced oxidative stress leads to DNA damage in the cerebellum of hyperbilirubinemic neonatal mice and activates DNA double strand break repair pathways in human cells

Rawat V, Bortolussi G, Gazzin S, Tiribelli C, Muro AF

Oxid Med Cell Longev 2018:1801243. doi: 10.1155/2018/1801243

2018

 

Histone acetylation as a new mechanism for bilirubin-induced encephalopathy in the Gunn rat

Vianello E, Zampieri S, Marcuzzo T, Tordini F, Bottin C, Dardis A, Zanconati F, Tiribelli C, Gazzin S

Sci Rep. 8(1):13690. doi: 10.1038/s41598-018-32106-w

2018

 

Blue or green for yellow? Which light is more beneficial for jaundiced newborns?

Tiribelli C

Pediatr Res.  Feb 21. doi: 10.1038/s41390-019-0350-7

2019

Oncogenicity of virus hepatitis b and c in the initiation of hepatic cancer stem cells

Sukowati CHC, Reyes AP, Tell G, Tiribelli C

Hepatoma Research 5:2

2019

 

Induction of mild hyperbilirubinemia: Hype or real therapeutic opportunity?

Bellarosa C, Vitek L, Tiribelli C

Clin Pharmacol Ther. Dec 27. doi: 10.1002/cpt.1341

2018

Two drinks per day does not take your fatty liver away

Bellentani S, Bedogni G, Tiribelli C

Hepatology. Jun;67(6):2072-2073. doi: 10.1002/hep.29753.

2018

A new stage in Annals of Hepatology

Panduro A, Tiribelli C, Chávez-Tapia NC, Uribe M

Ann Hepatol. 17(3):339-340. doi: 10.5604/01.3001.0011.7377.

2018

Where do we stand in the field of neonatal jaundice? Commentary on the 2017 J. Donald Osrow Trieste Yellow Retreat

Riordan S, Gazzin S

Pediatr Res. Jun;83(6):1090-1092. doi: 10.1038/pr.2018.53.

2018

Digital liver biopsy: standardized bio-imaging for translational and clinical research on fatty liver

Mancini M, Summers P, Faita F, Brunetto MR, Callea F, De Nicola A, Di Lascio N, Farinati F, Gastaldelli A, Gridelli B, Mirabelli P, Neri E, Salvadori PA, Rebelos E, Tiribelli C, Valenti LV, Salvatore M, Bonino F

                                                                                                                                                                                       World J Hepatol 10(2):231-245. doi: 10.4254/wjh.v10.i2.231                                                                                                                                                                      

2018

Global epidemiology of NAFLD/NASH: what we need in the future

Araújo AR, Rosso N, Bedogni G, Tiribelli C, Bellentani S

Liver Int. 38 Suppl 1:47-51. doi: 10.1111/liv.13643

2018

Aptamer: a potential oligonucleotide nanomedicine in the diagnosis and treatment of hepatocellular carcinoma

Ladju RB, Pascut D, Massi MN, Tiribelli C, Sukowati CHC

Oncotarget 9(2):2951-2961. doi: 10.18632/oncotarget.23359

2018

New molecular targets for functionalized nanosized drug delivery systems in personalized therapy for hepatocellular carcinoma

Turato C, Balasso A, Carloni V,  Tiribelli C, Mastrotto F,  Mazzocca A, Pontisso P

J Control Release 268:184-197. doi: 10.1016/j.jconrel.2017.10.027

2017